His primary areas of investigation include Stereochemistry, Reverse transcriptase, Nucleoside Reverse Transcriptase Inhibitor, Drug discovery and Computational biology. He combines subjects such as Structure–activity relationship, Chemical synthesis and Enzyme inhibitor with his study of Stereochemistry. His research integrates issues of Nevirapine and Biological activity in his study of Reverse transcriptase.
His work carried out in the field of Nucleoside Reverse Transcriptase Inhibitor brings together such families of science as Etravirine, Discovery and development of non-nucleoside reverse-transcriptase inhibitors, Virology, Diarylpyrimidines and Piperidine. His studies deal with areas such as Click chemistry and Pharmacology as well as Drug discovery. His Computational biology research includes elements of Pharmacophore, Acquired immunodeficiency syndrome and Drug.
The scientist’s investigation covers issues in Stereochemistry, Reverse transcriptase, Combinatorial chemistry, Virology and Potency. His Stereochemistry research incorporates elements of EC50, Design synthesis and Structure–activity relationship. His Reverse transcriptase study combines topics in areas such as Nevirapine and Cytotoxicity.
His Nevirapine research is multidisciplinary, incorporating elements of Delavirdine and Efavirenz. The various areas that Peng Zhan examines in his Combinatorial chemistry study include Binding site and Drug discovery. As part of the same scientific family, Peng Zhan usually focuses on Potency, concentrating on Pharmacology and intersecting with Drug resistance.
Peng Zhan mostly deals with Reverse transcriptase, Potency, Virology, Etravirine and Stereochemistry. The Reverse transcriptase study combines topics in areas such as Biochemistry, Strain, Design synthesis, Molecular biology and Drug. He has included themes like Pharmacokinetics, Pharmacology, Rational design, Enzyme and Diarylpyrimidines in his Potency study.
His Etravirine study combines topics from a wide range of disciplines, such as Nevirapine, Rilpivirine and Structure–activity relationship. His work in Structure–activity relationship addresses issues such as Nitrile, which are connected to fields such as Combinatorial chemistry. He studies Stereochemistry, namely Pyrimidine.
His scientific interests lie mostly in Drug discovery, Mechanism of action, Potency, Severe acute respiratory syndrome coronavirus 2 and Virology. Peng Zhan interconnects Virtual screening, Drug, Drug repositioning, Prodrug and Computational biology in the investigation of issues within Drug discovery. His study in Potency is interdisciplinary in nature, drawing from both EC50, Pharmacokinetics and Pyrimidine.
His Pharmacokinetics study incorporates themes from Thiophene and Piperidine, Stereochemistry. In most of his Piperidine studies, his work intersects topics such as Reverse transcriptase. His studies examine the connections between Drug resistance and genetics, as well as such issues in Nitrile, with regards to Combinatorial chemistry and Etravirine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: